Full Text
PCN20 COST-OF-ILLNESS- ECONOMIC EVALUATION OF PALLIATIVE 153SM-LEXIDRONAM RADIONUCLIDE TREATMENT IN PATIENTS WITH BONE PAIN SECONDARY TO METASTATIC PROSTATE CANCER

Abstract

Authors

FJ Papatheofanis MM Najib

Back to Volume 10, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×